TECX
Tectonic Therapeutic, Inc.
NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY
$27.97
+3.32% today
Updated 2026-04-30
Market cap
$512.68M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.05
Dividend yield
—
52W range
$14 – $36
Volume
0.3M
Tectonic Therapeutic, Inc. (TECX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.31M | $-16.38M | $-37.65M | $-67.67M | $-98.80M | $-12.45M | $-97.21M | $-40.68M | $-59.08M | $-60.08M |
| Capital expenditures | $0.00 | $383000.00 | $1.83M | $1.58M | $1.18M | $2.12M | $267000.00 | $279000.00 | $156000.00 | $208000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | $639000.00 | $1119.00 | $1.12M | $3.49M | $10.50M |
| Free cash flow | $-3.31M | $-16.77M | $-39.48M | $-69.25M | $-99.98M | $-14.58M | $-97.47M | $-40.96M | $-59.24M | $-60.29M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |